Gregory Cooper, M.D., Ph.D., joins Norton Neuroscience Institute

Gregory Cooper, M.D., Ph.D., neurologist and accomplished memory disorders researcher, has joined Norton Healthcare as medical director of the new Norton Neuroscience Institute Memory Center. Dr. Cooper was most recently medical director of memory care […]

View more

Registration open for the 2021 Neuroscience Symposium

The 2021 Neuroscience Symposium will be held Thursday, May 13, and Friday, May 14, 2021, and will provide the latest neurological information for health care providers serving adults, including primary care physicians, advanced practice providers, […]

View more

Perfusion scanning allows more time to save more brain

Time saved is brain saved, and in recent years we’ve gotten some more time to save more brain. In 2018, the American Heart and American Stroke associations updated their guidelines to say perfusion scanning can […]

View more

A baseline concussion test aids sports concussion diagnosis and treatment

A baseline concussion test provides data to measure functional change in an athlete, making it crucial to concussion care, according to Tad D. Seifert, M.D., a neurologist and sports concussion specialist who is director of […]

View more

Stroke in young people increasing and mostly preventable

Stroke in young people has been increasing, with adults as young as in their 20s at risk. This largely is due to more young people having risk factors previously associated with the older population: a […]

View more

Interventional treatments for episodic migraine

Interventional procedures may provide an option for patients with episodic migraine in cases where oral medications may be contraindicated because of comorbidities or because they don’t provide sufficient relief. Many of these treatments do not […]

View more

New drugs for MS patients

In the past year, patients with relapsing forms of multiple sclerosis (MS) have gotten three new treatment options. Mavenclad (cladribine) is the most groundbreaking of the new drugs, in my opinion, due to its unique […]

View more

One-year results of LAANTERN epilepsy study show seizure improvements

A new study published in Epilepsy Research found 64.3% of patients with various forms of drug-resistant epilepsy in the LAANTERN (Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System) registry were free of disabling […]

View more

How improving door-to-needle time saves lives

When a suspected stroke patient comes into the hospital, everyone on the team has assigned roles so care is delivered quickly and efficiently — picture a race car pit crew jumping over the railing to […]

View more

Study shows cluster headache medication can have long-term benefits

A drug used to relieve a cluster headache cycle also can help with subsequent cycles if patients continue the therapy, according to a new study by Norton Neuroscience Institute neurologist Brian M. Plato, D.O. Episodic […]

View more

Neuroscience Updates: ‘Migraine management and treatment options’

Join us Tuesday, Sept. 15, for a lunchtime series providing the latest updates in neuroscience. This program will be livestreamed from noon to 1 p.m. Mandy Whitt, M.D., headache specialist with Norton Neuroscience Institute, will […]

View more

Norton Brownsboro Hospital expansion opens

The expansion of Norton Brownsboro Hospital is complete, with 70 new patient beds — a 55% increase — advancements in stroke and aneurysm care capabilities and a larger emergency department. The new emergency department has […]

View more

Search our entire site.